Commercial Due Diligence in Digital Pathology

Project Overview

An early-stage venture firm requested a high-level commercial due diligence of a potential investment in the digital pathology space

DeciBio Approach

Primary Research

Conducted 13 interviews with experts from biopharma, clinical settings, and industry to assess the company's value proposition

Secondary Research

Assessed the competitive landscape and clinical workflows in specific indications to understand how the company's technology would integrate into the existing clinical paradigm

At a glance

Interviews

Key Competitors Profiled

Outcomes

DeciBio presented a deliverable detailing the digital pathology landscape, the company's ability to compete in the space, and potential go-to-market plans and considerations.

Quantitative Analysis

Company revenue estimation using comparable competitors as benchmarks

Qualitative Analysis

Potential clinical pricing / commercialization models
Timeline to clinic
Clinical go-to-market considerations by geography and stakeholder type

Timeline

4 weeks

Geographic Scope

U.S. and Europe

Industry

Pharma & Biotech

capabilities

Due Diligence

Revenue Projection

Competitive Analysis

Go-to-Market Strategy

Pricing Strategy

Novel Technology Commercialization

Cell and Gene Therapy Services Landscape Assessment

Cell and Gene Therapy Service Market Opportunity Assessment

Synthetic Oligonucleotides Market Sizing